Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients

Source :: Business Wire. August 28, 2024
Publication Year :: 2024
Abstract: NEW YORK -- Delcath Systems, Inc. (Nasdaq: DCTH) (the 'Company' or 'Delcath'), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced [...]

Subjects :: Delcath Systems Inc. -- Reports
Oncology, Experimental -- Reports
Metastasis -- Care and treatment -- Research
Liver -- Research -- Reports
Liver cancer -- Care and treatment -- Research
Cancer -- Research
Pharmaceutical industry -- Reports -- Research
Business
Business, international
Hepzato (Medication) -- Research -- Reports

Tools